The work to find a cure for cancer, debilitating age related illnesses and other medical issues on msubmit.net requires a concerted effort by a wide range of people. Quickly sharing the breakthroughs and new, pertinent information physicians and researchers discover helps others to build on their work, discover new possibilities and move medical science towards a cure much faster. One of the publications that helps to disseminate the information from the front lines of cancer research and treatment outcomes is Oncotarget. A peer-reviewed weekly open access medical journal, Oncotarget provides information dealing with research into all aspects of oncology.
Established in 2010, Oncotarget is produced by Impact Journals. Although the medical journal’s primary focus on EndNote.com is papers related to oncology, it also offers information on topics like Aging, Cardiology, Cell and Molecular Biology, Endocrinology, Gerotarget, Immunology, Metabolism, Microbiology, Neuropathology, Neuroscience and all areas of Pharmacology. The publication is abstracted and indexed in BIOSIS Previews, Scopus, Index Medicus/MEDLINE/PubMed and the Science Citation Index Expanded. In 2015 the journal had an impact factor of 5.008.
Oncotarget has two editors-in-chief. They are cancer researcher and educator Mikhail Blagosklonny and famed cancer researcher Dr. Andrei V. Gudkov of the Roswell Park Cancer Institute. These men have been able to attract papers by some of the most prominent and preeminent researchers and physicians. After an in-depth and intensive peer review process, the men see to it the information is available to stakeholders far and wide involved in cancer research and treatment and a number of related fields.
The results of two important studies were recently published in Oncotarget. One study dealt with the relationship between e-cigarettes and gum tissue damage. The other investigated the potential of MET amplification as a therapeutic target for helping people with gastric cancer. It’s the type of information many researchers and healthcare professionals have come to depend on Oncotarget to provide. The journal is a vital resource in the battle to cure cancer and many other diseases that plague mankind.
For the past 7 years, healthcare professionals and educators looking for the latest information on breakthroughs or cutting-edge treatments for cancer and aging related illnesses have come to see Oncotarget as a valuable resource. See: https://www.researchgate.net/journal/1949-2553_Oncotarget